{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:06:17Z","timestamp":1772197577631,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"DOI":"10.7759\/cureus.104376","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:28:07Z","timestamp":1772195287000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Semaglutide-Associated Small Bowel Obstruction Complicated by Acute Kidney Injury Requiring Dialysis"],"prefix":"10.7759","author":[{"given":"Suhasini","family":"Rallabandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnamraju","family":"Kosuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105782","article-title":"Anti-diabetic drugs and weight loss in patients with type 2 diabetes","volume":"171","author":"Lazzaroni E","year":"2021","unstructured":"Lazzaroni E, Ben Nasr M, Loretelli C, et al.. Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacol Res. 2021, 171:105782. 10.1016\/j.phrs.2021.105782","journal-title":"Pharmacol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70003","article-title":"How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?","volume":"182","author":"Weiskirchen R","year":"2025","unstructured":"Weiskirchen R, Lonardo A. How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?. Br J Pharmacol. 2025, 182:1651-70. 10.1111\/bph.70003","journal-title":"Br J Pharmacol"},{"key":"ref3","unstructured":"GLP-1 agonists. wonder drugs of the 21st century?. (2024). Accessed: February 5, 2026: https:\/\/medicine.yale.edu\/media-player\/glp-1-agonists-wonder-drugs-of-the-21st-century\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu L","year":"2022","unstructured":"Liu L, Chen J, Wang L, Chen C, Chen L. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database. Front Endocrinol (Lausanne). 2022, 13:1043789. 10.3389\/fendo.2022.1043789","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton S","year":"2022","unstructured":"Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, Pedersen SD. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022, 134:14-9. 10.1080\/00325481.2021.2002616","journal-title":"Postgrad Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning","volume":"49","author":"Kim JA","year":"2025","unstructured":"Kim JA, Yoo HJ. Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning. Diabetes Metab J. 2025, 49:525-41. 10.4093\/dmj.2025.0242","journal-title":"Diabetes Metab J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225886","article-title":"Lupus causing small bowel obstruction","volume":"2018","author":"Yang Y","year":"2018","unstructured":"Yang Y, Bartsch AM, Fryer E, Hancu D. Lupus causing small bowel obstruction. BMJ Case Rep. 2018, 2018:bcr2018225886. 10.1136\/bcr-2018-225886","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90657","article-title":"Nonmechanical small bowel obstruction in a patient on Zepbound without a surgical history: a case report","volume":"17","author":"Lorenz N","year":"2025","unstructured":"Lorenz N, Stauffer J, Abouafech A, Mourad A, Bray K. Nonmechanical small bowel obstruction in a patient on Zepbound without a surgical history: a case report. Cureus. 2025, 17:e90657. 10.7759\/cureus.90657","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88350","article-title":"Semaglutide-induced small bowel pseudo-obstruction and ileitis in a patient with type 2 diabetes: a case report","volume":"17","author":"Javed F","year":"2025","unstructured":"Javed F, Shaat IA, Oyibo SO. Semaglutide-induced small bowel pseudo-obstruction and ileitis in a patient with type 2 diabetes: a case report. Cureus. 2025, 17:e88350. 10.7759\/cureus.88350","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15611","article-title":"Actions of glucagon-like peptide-1 receptor ligands in the gut","volume":"179","author":"Holst JJ","year":"2022","unstructured":"Holst JJ, Andersen DB, Grunddal KV. Actions of glucagon-like peptide-1 receptor ligands in the gut. Br J Pharmacol. 2022, 179:727-42. 10.1111\/bph.15611","journal-title":"Br J Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81891","article-title":"GLP-1 receptor agonists in diabetes and obesity: a case report and review of bowel obstruction risks and management","volume":"17","author":"Jones M","year":"2025","unstructured":"Jones M, Cappola JJ. GLP-1 receptor agonists in diabetes and obesity: a case report and review of bowel obstruction risks and management. Cureus. 2025, 17:e81891. 10.7759\/cureus.81891","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1493","article-title":"Exenatide associated renal failure","volume":"27","author":"Bhatti R","year":"2010","unstructured":"Bhatti R, Flynn MD, Illahi M, Carnegie AM. Exenatide associated renal failure. Pract Diabetes Int. 2010, 27:232-4. 10.1002\/pdi.1493","journal-title":"Pract Diabetes Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae250","article-title":"Semaglutide-associated kidney injury","volume":"17","author":"Begum F","year":"2024","unstructured":"Begum F, Chang K, Kapoor K, et al.. Semaglutide-associated kidney injury. Clin Kidney J. 2024, 17:sfae250. 10.1093\/ckj\/sfae250","journal-title":"Clin Kidney J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic V","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, et al.. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024, 391:109-21. 10.1056\/NEJMoa2403347","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464959-a-rare-case-of-semaglutide-associated-small-bowel-obstruction-complicated-by-acute-kidney-injury-requiring-dialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:28:07Z","timestamp":1772195287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464959-a-rare-case-of-semaglutide-associated-small-bowel-obstruction-complicated-by-acute-kidney-injury-requiring-dialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.104376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}